A Reproductive and Developmental Medicine student

The Medical School

We train world class clinicians and researchers who prolong and improve lives every day.

Undergraduate study

An undergraduate medical lecture
MBChB Medicine 
An oncology student in the lab
Intercalation 

Postgraduate study

A Reproductive and Developmental Medicine student
Postgraduate taught courses 
A PhD student in the lab
PhD study 

Our research

A medical researcher in the lab

Research themes

We conduct world-leading research across a range of specialist themes including oncology, reproduction, neuroscience, infection, immunity and medical education.

Our research themes and centres

Nerve cells

Flagship institutes

Our flagship research institutes bring together our key research strengths to turn interdisciplinary and translational research into real-world solutions.

Explore our flagship institutes

Head up collar

The Goldilocks Collar

A special collar developed by University scientists has been giving the independence back to motor neurone disease patients all over the world.

Our patient-centred approach to transforming lives

About us

A medicine undergraduate student
Meet our students 
The Athena Swan Silver Award Logo
Athena SWAN 
The Sheffield Medical School
Social accountability 

News

A male patient having a blood sample taken during a clinical trial
11 December 2019

University of Sheffield Cardiovascular Research Unit lead world's first trial of new heart attack drug treatment

Research has shown that a new drug, selatogrel, may provide an alternative treatment for patients during the early stages of a heart attack.
SITraN Building
21 November 2019

Royal recognition for neuroscience research at the University of Sheffield

The University of Sheffield has been awarded the Queen's Anniversary Prize for innovation in neuroscience
Lungs
15 November 2019

Pulmonary arterial hypertension targeted for new treatment by University of Sheffield scientists

Scientists at the University of Sheffield, working in collaboration with drug and vaccine developer Kymab Ltd, Cambridge, have identified a novel antibody that has the potential to become a new treatment for pulmonary arterial hypertension (PAH).

Our departments

Academic Unit of Medical Education

Department of Infection, Immunity and Cardiovascular Disease

Department of Neuroscience

Department of Oncology and Metabolism

Working with industry

Sheffield Healthcare Gateway provides a single point of access for business to the University of Sheffield's healthcare facilities and expertise

Ask us a question

Browse our frequently asked questions, or ask a question of your own:

AskUS